What Researchers Did
Researchers conducted a narrative review to report on current and investigational therapies for preventing or treating delayed neurological syndrome following carbon monoxide poisoning.
What They Found
The review found that hyperbaric oxygen administration, while a current prevention strategy, remains controversial due to a lack of evidence regarding its efficacy. It also identified several other therapies under investigation that show promising results in humans for preventing or improving delayed neurological syndrome.
What This Means for Canadian Patients
Canadian patients who survive carbon monoxide poisoning may benefit from the development of more effective and evidence-based therapies to prevent or treat delayed neurological syndrome. This research highlights the ongoing need for improved interventions beyond current controversial treatments.
Canadian Relevance
This study has no specific Canadian connection mentioned in the metadata or abstract.
Study Limitations
As a narrative review, this study may be limited by potential selection bias in the included therapies and the absence of a systematic review methodology.